Saxenda denied by insurance? Appeal and win.
A Saxenda denial is rarely the final word. It is the start of a process. Most denials come down to two things: a prior authorization that did not document the patient's BMI, weight-related conditions, and prior weight-loss efforts, or a plan that carves out weight-management drugs entirely. The first is fixable with a clean clinical record that maps directly to the plan's own criteria; the second requires a different path, usually a formulary exception or a careful read of exactly what the plan excludes. Knowing which denial you are facing is what flips the outcome.
Reviewed by the Apellica Appeals Team · Updated June 2026
Carrier names and logos are trademarks of their respective owners. Apellica is independent and not affiliated with any insurance carrier or carrier's appeal program.
Saxenda (liraglutide) is FDA-approved as an addition to a reduced-calorie diet and increased physical activity for chronic weight management. In adults it is indicated for those with obesity (a BMI of 30 or higher) or who are overweight (a BMI of 27 or higher) and also have at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol. It is also approved for adolescents aged 12 to 17 who have obesity by age- and sex-specific BMI standards and who weigh more than 60 kg (about 132 pounds). Saxenda is not approved to treat type 2 diabetes on its own, and it should not be combined with another GLP-1 receptor agonist.
Why Saxenda gets denied
- Benefit exclusion: many employer and individual plans carve out weight-management drugs as a category, so coverage is refused regardless of medical need.
- BMI and comorbidity criteria not documented: the prior authorization did not clearly show a BMI of 30 or higher, or a BMI of 27 or higher with a qualifying weight-related condition.
- No record of prior weight-loss efforts: most plans require a documented trial of diet, exercise, and behavioral changes, often supervised for 3 to 6 months, before approving Saxenda.
- Continuation denied at reauthorization: the plan requires proof of clinically meaningful weight loss (commonly at least 4 percent of starting weight by week 16) and the record did not show it.
What a winning appeal includes
- A documented BMI that meets the plan threshold (30 or higher, or 27 or higher with a comorbidity), with the qualifying condition named and coded, for example E66.9 for obesity and the relevant ICD-10 code for hypertension, type 2 diabetes, or dyslipidemia.
- A clear history of prior weight-loss attempts: documented diet and exercise programs, dates, and any earlier weight-management medications tried and their results.
- A letter of medical necessity from the prescriber that maps each plan criterion to the patient's chart and explains why Saxenda is appropriate.
- For continuation appeals, weight measurements over time showing the required response (such as at least 4 percent loss by 16 weeks) to satisfy the plan's reauthorization rule.
How we approach the appeal
First identify the denial type, because the path depends on it. If the plan covers weight-management drugs but the prior authorization fell short, appeal the medical-necessity decision by quoting the plan's own PA criteria line by line and attaching documentation for each one, including BMI, comorbidities, and prior therapy. If the drug is non-formulary or on a high tier, request a formulary or tier exception rather than a standard appeal. If the plan flatly excludes weight-loss medications as a benefit category, a medical-necessity argument usually will not override that language, so the realistic options are a formulary exception request, an external review where allowed, or asking the employer to amend the benefit at open enrollment.
Saxenda appeal letter template
Copy this Saxenda appeal letter, fill in the brackets, and send it within your deadline. It is built on what overturns GLP-1 receptor agonist (once-daily injectable) denials.
[Date] [Your name] · Member ID [ID] · Rx claim # [#] [Insurer or PBM] - Appeals Department Re: Appeal of Saxenda denial I am appealing the denial of Saxenda (liraglutide). I request that the denial be overturned and Saxenda approved. 1. The denial. [Insurer] denied Saxenda stating, verbatim: "[paste the exact denial reason from your letter]." 2. Medical necessity. Saxenda is medically necessary for my condition. First identify the denial type, because the path depends on it. If the plan covers weight-management drugs but the prior authorization fell short, appeal the medical-necessity decision by quoting the plan's own PA criteria line by line and attaching documentation for each one, including BMI, comorbidities, and prior therapy. If the drug is non-formulary or on a high tier, request a formulary or tier exception rather than a standard appeal. If the plan flatly excludes weight-loss medications as a benefit category, a medical-necessity argument usually will not override that language, so the realistic options are a formulary exception request, an external review where allowed, or asking the employer to amend the benefit at open enrollment. 3. Step-therapy or formulary exception (if that was the reason): I have tried and failed [preferred drug(s)], with pharmacy records attached, or the preferred alternative is contraindicated because [reason]. I request a formulary or step-therapy exception. 4. My request. Approve Saxenda within the timeframe required by law. If the denial is upheld, please provide the specific criteria used, the reviewing clinician's credentials, and external-review instructions. Attached: prescriber letter of medical necessity, pharmacy and prior-trial records, and supporting clinical notes. Sincerely, [Your name]
Want it built and filed for you? Use the free generator, or have Apellica do it.
Internal appeals: 30 days pre-service, 60 days post-service, 72 hours urgent. File within 180 days of the denial.
$0 upfront. We assess fit first, then build and file the appeal for you.
- · The denial letter and your Explanation of Benefits (EOB)
- · Insurance ID, plan name, and the claim or prior-authorization number
- · Diagnosis with ICD-10 code and the prescriber's clinical notes
- · A record of treatments already tried and how they worked
Appealing a Saxenda denial by insurer
The path depends on who manages your benefit. The most common:
Coverage runs through the pharmacy benefit. Appeal the coverage determination and, when the drug is non-formulary, file a formulary or tier exception with a provider attestation that covered alternatives are unsuitable.
Publishes detailed prior-authorization criteria. A denial usually means a criterion was not documented. Appeal through a coverage review, with a formulary exception for excluded drugs.
Administers many UnitedHealthcare and employer plans. Appeals and exceptions follow the plan's published PA criteria; expedited review exists for urgent cases.
Internal appeal first, then independent external review. Pre-service decisions are generally made within 30 days, urgent within 72 hours.
Internal appeals and external review; pharmacy denials often route through OptumRx criteria.
Independent state plans, so criteria vary. Match the appeal to your specific BCBS plan, internal appeal first, then external review.
Frequently asked questions
My plan says it does not cover weight-loss drugs at all. Can I still appeal a Saxenda denial?
If the plan has a true benefit exclusion for weight-management medications, a medical-necessity appeal usually cannot force coverage, because the denial is based on plan design rather than your clinical situation. It is still worth confirming the exact exclusion language, since some plans cover GLP-1s for other approved uses, and you can request a formulary exception or pursue external review where your state allows it. For employer plans, asking HR to add the benefit at the next open enrollment is often the most realistic route.
What documentation gives a Saxenda appeal the best chance?
A documented BMI that meets the plan's threshold, the qualifying weight-related condition named and coded, a record of prior diet and exercise efforts, and a letter of medical necessity that ties each of the plan's stated criteria to your chart. Mapping your records point by point to the plan's own prior authorization rules is far more persuasive than a general statement that the drug is needed.
My insurer approved Saxenda before but denied the refill. Why?
Many plans approve Saxenda for an initial period and then require proof of response before they will continue it. A common rule is showing at least about 4 percent loss of your starting body weight by around 16 weeks. If your refill was denied, the appeal should include weight measurements over time that demonstrate the response the plan requires for reauthorization, along with your prescriber's confirmation that continued treatment is appropriate.
Saxenda denied? We fight it for you.
$0 upfront. Two-minute intake. We confirm fit and reply within one business day with the right path for your situation.
Start Your AppealThis page provides general information about appeal strategy. It is not legal or medical advice. Apellica is not a law firm. Outcomes depend on documentation, plan terms, and timing.